Barclays Portfolio holdings
Barclays PLC, founded in 1690 by goldsmith bankers in London, is a British multinational financial institution headquartered in London, operating as one of the world’s oldest banks with a significant presence in investment banking, retail banking, and wealth management. Managing billions in assets, Barclays serves millions of customers globally through its retail arm (notably in the UK) and its investment banking division, which excels in trading, mergers and acquisitions, and capital markets, competing with Wall Street giants. The bank has navigated challenges like the 2008 financial crisis—opting for private funding over a government bailout—and has since focused on restructuring, digital innovation, and sustainable finance initiatives. With a rich history and a modern global footprint, Barclays remains a key player in both UK and international financial markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares US Real Estate ETF
IYR
|
+$947M |
| 2 |
Tesla
TSLA
|
+$608M |
| 3 |
Microsoft
MSFT
|
+$444M |
| 4 |
Accenture
ACN
|
+$409M |
| 5 |
iShares MSCI Emerging Markets ETF
EEM
|
+$396M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CRH
CRH
|
+$2.06B |
| 2 |
Texas Instruments
TXN
|
+$1.92B |
| 3 |
Meta Platforms (Facebook)
META
|
+$1.81B |
| 4 |
Starbucks
SBUX
|
+$1.42B |
| 5 |
State Street Consumer Discretionary Select Sector SPDR ETF
XLY
|
+$1,000M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 19.52% |
| 2 | Financials | 7.13% |
| 3 | Consumer Discretionary | 6.46% |
| 4 | Healthcare | 5.43% |
| 5 | Communication Services | 5.15% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
4476
AXT Inc
AXTI
$3.07B
| $84.2K | ﹤0.01% |
+34,778
| New | +$98.4K |
|
4477
iShares MSCI Indonesia ETF
EIDO
$480M
| $83.3K | ﹤0.01% |
3,700
| – | – |
|
|
DOO
4478
Bombardier Recreational Products
DOO
$4.58B
| $82.4K | ﹤0.01% |
1,384
+176
| +15% | +$11.7K |
|
4479
Stem
STEM
$47.5M
| $81.9K | ﹤0.01% |
11,767
+8,008
| +213% | +$126K |
|
4480
Upland Software
UPLD
$13.6M
| $81.8K | ﹤0.01% |
3,286
| – | – |
|
|
MOND
4481
DELISTED
Mondee Holdings, Inc. Class A Common Stock
MOND
| $81.5K | ﹤0.01% |
58,667
+41,271
| +237% | +$87.4K |
|
|
FSFG
4482
DELISTED
First Savings Financial Group
FSFG
| $80.9K | ﹤0.01% |
3,396
+1,432
| +73% | +$31.4K |
|
4483
Actinium Pharmaceuticals
ATNM
$26.3M
| $80.7K | ﹤0.01% |
42,935
+32,784
| +323% | +$130K |
|
|
RPT
4484
Rithm Property Trust
RPT
$97.2M
| $80.6K | ﹤0.01% |
+4,036
| New | +$83.9K |
|
4485
iShares MSCI Europe Small-Cap ETF
IEUS
$180M
| $79.9K | ﹤0.01% |
1,320
| – | – |
|
|
RAPT
4486
DELISTED
RAPT Therapeutics
RAPT
| $79.9K | ﹤0.01% |
4,966
+3,649
| +277% | +$73.8K |
|
4487
Karyopharm Therapeutics
KPTI
$159M
| $79.5K | ﹤0.01% |
6,384
-51,834
| -89% | -$644K |
|
4488
GSK
GSK
$104B
| $79.3K | ﹤0.01% |
1,939
-97,527
| -98% | -$3.99M |
|
4489
Motorcar Parts of America
MPAA
$260M
| $79.1K | ﹤0.01% |
+10,710
| New | +$66.4K |
|
4490
PUT
Fortive
FTV
$17.7B
| $78.9K | ﹤0.01% |
+1,327
| New | +$73K |
|
4491
Galectin Therapeutics
GALT
$213M
| $78.6K | ﹤0.01% |
28,587
+21,598
| +309% | +$53K |
|
4492
Critical Metals Corp
CRML
$817M
| $77.9K | ﹤0.01% |
10,473
+7,996
| +323% | +$71.7K |
|
4493
Direxion Daily 7-10 Year Treasury Bear 3X ETF
TYO
$12.4M
| $77.5K | ﹤0.01% |
6,182
| – | – |
|
4494
Beamr Imaging
BMR
$18.9M
| $77.4K | ﹤0.01% |
+20,000
| New | +$83.5K |
|
4495
Ramaco Resources Class B
METCB
$431M
| $77.3K | ﹤0.01% |
7,749
+5,910
| +321% | +$59.3K |
|
|
SWKH
4496
DELISTED
SWK Holdings
SWKH
| $77.1K | ﹤0.01% |
5,630
+3,655
| +185% | +$49.6K |
|
4497
Ericsson
ERIC
$32.1B
| $76.7K | ﹤0.01% |
10,124
-90
| -0.9% | -$630 |
|
|
NIU
4498
Niu Technologies
NIU
$203M
| $76.5K | ﹤0.01% |
33,245
| – | – |
|
|
NNE
4499
Nano Nuclear Energy
NNE
$896M
| $76.4K | ﹤0.01% |
+5,304
| New | +$74.6K |
|
4500
PUT
BioCryst Pharmaceuticals
BCRX
$2.35B
| $76K | ﹤0.01% |
+10,000
| New | +$76K |
|
Similar funds
Barclays's Q3 2024 Portfolio in Review
As of Q3 2024, Barclays held 5,593 positions worth $377B, up 15% from $327B the previous quarter. Its ten largest holdings account for 41% of the portfolio.
Barclays deployed $31.3B of net new capital in Q3 2024, opening 785 new positions and adding to 2,954 existing holdings. Its largest new stake was Smurfit Westrock: 3,460,710 shares worth $171M.
By sector, the portfolio is most concentrated in Technology at 20% of assets, down from 22% a quarter earlier, followed by Financials and Consumer Discretionary.
On the sell side, the largest reduction was CRH, an estimated $2.06B trimmed.
- Barclays's largest Q3 2024 buy was Smurfit Westrock: 3,460,710 shares worth $171M.
- Barclays added most to iShares US Real Estate ETF in Q3 2024, an estimated $947M increase.
- Barclays's biggest Q3 2024 reduction was CRH, cutting an estimated $2.06B.
- Barclays fully exited Equitrans Midstream Corporation Common Stock in Q3 2024, selling an estimated $51.3M.
- Barclays's ten largest holdings make up 41% of its $377B portfolio in Q3 2024.
- Barclays opened 785 new positions and closed 322 in Q3 2024.
- Barclays's portfolio value rose 15% quarter-over-quarter to $377B.
Based on Barclays's 13F filing for Q3 2024, filed 15 Nov 2024.